⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QURE News
uniQure N.V.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines - QURE
prnewswire.com
QURE
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
QURE
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Kyndryl Holdings, Inc. (KD), uniQure N.V. (QURE), and REGENXBIO Inc. (RGNX) Announced by Holzer & Holzer, LLC
globenewswire.com
KD
QURE
RGNX
QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of uniQure N.V. to Contact the Firm Today!
accessnewswire.com
QURE
INVESTOR DEADLINE: uniQure (QURE) Investors with Substantial Losses Have Opportunity to Lead the uniQure Class Action Lawsuit– Hagens Berman
globenewswire.com
QURE
Pomerantz LLP Notifies Shareholders of Class Action Against uniQure N.V. – QURE
accessnewswire.com
QURE
Class Action Reminder from Pomerantz LLP for Investors of uniQure N.V. – QURE
accessnewswire.com
QURE
QURE Stockholders Have Opportunity to Lead uniQure N.V. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
QURE
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
globenewswire.com
QURE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE
globenewswire.com
QURE